Xiao‐En Xu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- RNA modifications and cancer 4
- RNA Research and Splicing 3
- Glycosylation and Glycoproteins Research 2
- Ubiquitin and proteasome pathways 2
-
- Cancer-related molecular mechanisms research 5
- Co-authors
- Xi Jin (12 shared papers)Ke‐Da Yu (7 shared papers)Yi-Zhou Jiang (6 shared papers)Yi‐Rong Liu (6 shared papers)Zhi‐Ming Shao (7 shared papers)Zhi-Ming Shao (6 shared papers)Da‐Qiang Li (6 shared papers)Xin Hu (4 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Journal of Proteomics (2 papers)Cancer Research (2 papers)Tumor Biology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- ChinaUnited StatesLaos
In The Last Decade
Xiao‐En Xu
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 81
- Cancer Research 552
- Oncology 278
- Molecular Biology 702
- Immunology 112
- Pulmonary and Respiratory Medicine 143
Countries citing papers authored by Xiao‐En Xu
This map shows the geographic impact of Xiao‐En Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐En Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐En Xu more than expected).
Fields of papers citing papers by Xiao‐En Xu
This network shows the impact of papers produced by Xiao‐En Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐En Xu. The network helps show where Xiao‐En Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao‐En Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 175 | |
| 2 | 2016 | 161 | |
| 3 | 2010 | 110 | |
| 4 | 2019 | 99 | |
| 5 | 2016 | 74 | |
| 6 | 2020 | 71 | |
| 7 | 2021 | 63 | |
| 8 | 2016 | 63 | |
| 9 | 2010 | 55 | |
| 10 | 2021 | 42 | |
| 11 | 2013 | 37 | |
| 12 | 2014 | 36 | |
| 13 | 2018 | 33 | |
| 14 | 2020 | 33 | |
| 15 | 2015 | 33 | |
| 16 | 2019 | 32 | |
| 17 | 2018 | 29 | |
| 18 | 2020 | 28 | |
| 19 | 2015 | 22 | |
| 20 | 2019 | 21 |
About Xiao‐En Xu
Xiao‐En Xu is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Spectroscopy, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers), Advanced Proteomics Techniques and Applications (3 papers), RNA Research and Splicing (3 papers), Peptidase Inhibition and Analysis (3 papers), Glycosylation and Glycoproteins Research (2 papers), Ubiquitin and proteasome pathways (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Cancer Research (552 citations), Oncology (278 citations), Molecular Biology (702 citations), Immunology (112 citations) and Pulmonary and Respiratory Medicine (143 citations). Xiao‐En Xu has collaborated with scholars based in China, United States and Laos. Frequent co-authors include Xi Jin, Ke‐Da Yu, Yi-Zhou Jiang, Yi‐Rong Liu, Zhi‐Ming Shao, Zhi-Ming Shao, Da‐Qiang Li, Xin Hu, Yi‐Zhou Jiang and Xin Hu. Their work appears in journals such as Clinical Cancer Research, Journal of Proteomics, Cancer Research, Tumor Biology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.